In line with this, co-cultures of TMEM123+ CD8+ T lymphocytes with CRC tumoroids further demonstrated that TMEM123 expression is required for the directional migration of CD8+T cells towards the organoid, which is pivotal for further attacking and eliminating the cancer cells. The gene discussed is CD8A; the disease is cancer.